Ophthalmology Market Research Reports & Industry Analysis
Ophthalmology Industry Research & Market Reports
-
Ophthalmic Drugs
... CAGR of 6.2% over the analysis period 2024-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$34.7 Billion by the end of the analysis ... Read More
-
Ophthalmic Pharmaceutical Drugs
... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More
-
Punctal Plug Devices
... at a CAGR of 8.3% over the analysis period 2024-2030. Absorbable / Temporary Punctal Plug Devices, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$83.3 Million ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Ophthalmic Femtosecond Lasers
... at a CAGR of 4.6% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million by the end ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
-
Ophthalmic Eye Dropper
... at a CAGR of 3.8% over the analysis period 2024-2030. Preserved multi-Dose Eye Droppers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$10.3 Billion by the ... Read More
-
Ophthalmic Examination Chairs
... at a CAGR of 4.7% over the analysis period 2024-2030. Electric Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$60.0 Million by the end of ... Read More
-
Veterinary Eye Care
... at a CAGR of 3.5% over the analysis period 2024-2030. Diagnosis, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$3.8 Billion by the end of the ... Read More
-
Ocular Inflammation Treatment
... at a CAGR of 4.1% over the analysis period 2024-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$432.7 Million by the end of the ... Read More
-
Retinal Laser Equipment
... at a CAGR of 7.1% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$693.0 Million by the end of the ... Read More
-
Vitreous Tamponades
... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis period. ... Read More
-
Diabetes Associated Ophthalmic Treatment
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Diabetic Ophthalmic Drugs, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.9 Billion by ... Read More
-
Ophthalmic Perimeters
... CAGR of 2.6% over the analysis period 2024-2030. Static Ophthalmic Perimeters, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$142.5 Million by the end of the ... Read More
-
Ophthalmic Supply
... CAGR of 4.1% over the analysis period 2024-2030. Ophthalmic Vision Care Devices, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.2 Billion by the end of ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Blepharitis Drugs
... CAGR of 3.3% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Ophthalmic Lasers
... CAGR of 5.0% over the analysis period 2024-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis ... Read More
-
Glaucoma Therapeutics
... CAGR of 3.5% over the analysis period 2024-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Ophthalmic Loupes
... CAGR of 5.8% over the analysis period 2024-2030. Galilean Loupes, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$470.5 Million by the end of the analysis ... Read More
-
Emergency Shower & Eyewash Stations
... Million by 2030, growing at a CAGR of 2.0% over the analysis period 2024-2030. Emergency shower station, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$288.0 ... Read More
-
Lacrimal Duct Stent Tubes
... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More
-
Eye Allergy Therapeutics
... at a CAGR of 5.5% over the analysis period 2024-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Aesthetic Ophthalmology Devices
... at a CAGR of 7.9% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$837.6 Million by the end of ... Read More
Research Assistance
